flucytosine has been researched along with Sporothrix brasiliensis Infection in 20 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 7.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "Intravenous miconazole, an investigational, broad-spectrum, antifungal imidazole drug, was clinically effective when used for the first time in a patient with life-threatening sporotrichosis." | 7.65 | Pulmonary sporotrichosis: Treatment with miconazole. ( Archer, G; Rohwedder, JJ, 1976) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 3.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "Intravenous miconazole, an investigational, broad-spectrum, antifungal imidazole drug, was clinically effective when used for the first time in a patient with life-threatening sporotrichosis." | 3.65 | Pulmonary sporotrichosis: Treatment with miconazole. ( Archer, G; Rohwedder, JJ, 1976) |
| "The deep mycoses are increasing in importance both as opportunistic infections and from exposure in geographically defined areas." | 2.37 | Cutaneous and mucosal manifestations of the deep mycotic infections. ( Meyer, RD, 1986) |
| "Sporotrichosis is a subcutaneous and chronic infection caused by traumatic inoculation of pathogenic sporothrix species, usually infecting the skins and subcutaneous tissues of humans and animals." | 1.91 | Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China. ( Cai, W; Fang, J; Huang, J; Li, J; Lin, L; Lu, S; Zhang, J, 2023) |
| "Although blastomycosis is endemic in North America, only 4 cases have been identified in Natal during the last 25 years, and all presented with atypical clinical features." | 1.28 | Tropical mycoses. ( Bayles, MA, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (60.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarado-Ramírez, E | 1 |
| Torres-Rodríguez, JM | 1 |
| Marimon, R | 1 |
| Serena, C | 1 |
| Gené, J | 1 |
| Cano, J | 1 |
| Guarro, J | 1 |
| Lin, L | 1 |
| Huang, J | 1 |
| Fang, J | 1 |
| Li, J | 1 |
| Cai, W | 1 |
| Zhang, J | 1 |
| Lu, S | 1 |
| Córdoba, S | 1 |
| Isla, G | 1 |
| Szusz, W | 1 |
| Vivot, W | 1 |
| Hevia, A | 1 |
| Davel, G | 1 |
| Canteros, CE | 1 |
| Kantarcioğlu, AS | 1 |
| Boekhout, T | 1 |
| De Hoog, GS | 1 |
| Theelen, B | 1 |
| Yücel, A | 1 |
| Ekmekci, TR | 1 |
| Fries, BC | 1 |
| Ikeda, R | 1 |
| Koslu, A | 1 |
| Altas, K | 1 |
| Shelley, WB | 1 |
| Sica, PA | 1 |
| Beardmore, GL | 1 |
| Utz, JP | 2 |
| Rohwedder, JJ | 1 |
| Archer, G | 1 |
| Barfuss, T | 1 |
| Seeliger, HP | 1 |
| Plempel, M | 1 |
| Stretcher, GS | 1 |
| Smith, JG | 1 |
| Bayles, MA | 1 |
| Van Cutsem, J | 1 |
| Meyer, RD | 1 |
| Riley, HD | 1 |
| Newberry, WM | 1 |
| Abernathy, RS | 1 |
| Block, ER | 1 |
| Jennings, AE | 1 |
| Bennett, JE | 1 |
2 reviews available for flucytosine and Sporothrix brasiliensis Infection
| Article | Year |
|---|---|
Cutaneous and mucosal manifestations of the deep mycotic infections.
Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosi | 1986 |
Drug treatment of the systemic mycoses.
Topics: Actinomycosis; Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidi | 1972 |
18 other studies available for flucytosine and Sporothrix brasiliensis Infection
| Article | Year |
|---|---|
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazo | 2007 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Sp | 2008 |
Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China.
Topics: Amphotericin B; Animals; Antifungal Agents; China; Flucytosine; Humans; Itraconazole; Microbial Sens | 2023 |
Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina.
Topics: Animals; Antifungal Agents; Argentina; Calmodulin; Flucytosine; Humans; Itraconazole; Microbial Sens | 2018 |
Subcutaneous cryptococcosis due to Cryptococcus diffluens in a patient with sporotrichoid lesions case report, features of the case isolate and in vitro antifungal susceptibilities.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Base Sequence; Cryptococcosis; Cryptococcus; Diagnosi | 2007 |
Disseminate sporotrichosis of skin and bone cured with 5-fluorocytosine: Photosensitivity as a complication.
Topics: Adult; Amphotericin B; Bone Diseases; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Male | 1983 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom | 1997 |
Recalcitrant sporotrichosis: a report of a patient treated with various therapies including oral miconazole and 5-fluorocytosine.
Topics: Administration, Oral; Adult; Amphotericin B; Cautery; Cryosurgery; Curettage; Cytosine; Dermatomycos | 1979 |
The current status of chemotherapeutic agents for the systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Clotrimazole; Flucytosine; Humans; Miconazole; Myc | 1977 |
Pulmonary sporotrichosis: Treatment with miconazole.
Topics: Amphotericin B; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combinat | 1976 |
[Further experimental data on clotrimazole: effectiveness against Cryptococcus neoformans, Sporothrix schenkii and Blastomyces dermatitidis Gilchrist].
Topics: Amphotericin B; Animals; Blastomyces; Clotrimazole; Cryptococcosis; Cryptococcus; Cryptococcus neofo | 1975 |
Diagnosis and treatment of cutaneous fungus diseases.
Topics: Actinomycosis; Amphotericin B; Blastomycosis; Candida albicans; Candidiasis, Cutaneous; Chromoblasto | 1975 |
Tropical mycoses.
Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Chromoblastomycosis; Drug Therapy, Combination; Femal | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1992 |
Chemotherapy of the systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Flucytosine; H | 1973 |
Systemic mycoses in children. II.
Topics: Actinomycosis; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Female; | 1972 |
Treatment of systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cr | 1973 |
Experimental therapy of cladosporiosis and sporotrichosis with 5-fluorocytosine.
Topics: Animals; Antifungal Agents; Cytosine; Flucytosine; Male; Mice; Mitosporic Fungi; Mycoses; Sporotrich | 1973 |